General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.
1. Opening Hook
There is a way to open an earnings call, and then there is what Dr. Kailash Katkar did. He told the room that revenue “has remained stagnant over the decade and even degrowing for the last two years,” that the roughly Rs. 100 crores of annual profit the company used to post “has eroded,” and that FY26 closed with a loss of over Rs. 10 crores.
Then, for good measure: management called it “the worst quarter in terms of profitability in the history of Quick Heal.” That is the CEO — sorry, the Managing Director — describing his own numbers, unprompted.
FY26 revenue landed at Rs. 261 crores against Rs. 280 crores last year. The full-year operating loss was Rs. 29 crores. And the explanation offered for all of it was a single, load-bearing word. Read on.
2. At a Glance
- FY26 revenue Rs. 261 Cr (down from Rs. 280 Cr) – Degrowth, arriving on schedule for a third straight year.
- FY26 operating loss Rs. 29 Cr – The full year’s entire EBITDA hole opened in the March quarter alone.
- PAT Rs. -11 Cr vs Rs. +5 Cr – The profit didn’t shrink; it changed sign.
- Q4 sales Rs. 49 Cr, down 25% – The quarter management itself nominated as the worst on record.
- FY26 EPS Rs. -2.01 – Ten years of the company’s history, and this is the second-worst EPS in it.
- Enterprise now “more than 50%” of top line, management said – Half the business is finally growing; the other half is doing the loss.
3. Management’s Key Commentary
Five to seven quotes, decoded.
“The answer is simple, we have been transforming.” — Kailash Katkar (The word explaining a decade of flat revenue and two years of degrowth. It is being asked to carry a lot.)
“transforming the DNA of the organization to make this happen.” — Kailash Katkar (When operating profit swings from Rs. 141 Cr in FY21 to negative Rs. 29 Cr, “DNA” is one way to describe it.)
“this is the worst quarter in terms of profitability in the history of Quick Heal for as long as I can remember.” — Kailash Katkar (Full marks for accuracy. The Rs. -20 Cr net loss in Q4 agrees with him completely.)
“I am bullish about the future even though the quarter and yearly finance results are not very encouraging.” — Kailash Katkar (“Not very encouraging” is the year’s finest understatement, narrowly beating the loss itself.)
“This has been a mixed year for us from a performance standpoint.” — Ankit Maheshwari (Mixed, in the sense that revenue fell and the profit disappeared at the same time.)
“the IT hardware market witnessed significant price inflation of up to 400% during 2026 compared to 2025.” — Ankit Maheshwari (Hardware prices didn’t rise. They quadrupled. The channel noticed.)
“in line with our prudent accounting practices, all R&D investments continue to be fully expensed off in the year incurred.” — Ankit Maheshwari (“Prudent” — the adjective that arrives precisely when a line item is hurting the P&L.)
“our overdues have improved significantly, which was Rs. 167 crores at the end of last year, had further went up to Rs. 176 crores at the end of H1, now stands at Rs. 138 crores.” — Ankit Maheshwari (Improved, in the sense that they first got worse to Rs. 176 Cr and then came back below where they started.)
4. Numbers Decoded
Year-end call, so the full-year figures lead, with
